Ciaran J. McMullan
0000-0001-7269-6391
Publication & Citation Trends
Publications
0 total
Baseline Characteristic Of Participants In The Victor (Vericiguat Global Study In Participants With Chronic Heart Failure) Trial Global Study In Participants With Chronic Heart Failure) Trial:
Cited by 0
Semantic Scholar
Baseline characteristics of contemporary trial participants with heart failure and reduced ejection fraction: The VICTOR trial
Cited by 15
Semantic Scholar
Characterizing real-world use of vericiguat in the US.
Cited by 3
Semantic Scholar
Projecting the benefit of vericiguat in PARADIGM‐HF and DAPA‐HF populations: Insights from the VICTORIA trial OA
Cited by 3
Semantic Scholar
Vericiguat Global Study in Participants with Chronic Heart Failure: Design of the VICTOR trial
Cited by 27
Semantic Scholar
Diuretic use and outcomes in patients with heart failure with reduced ejection fraction: Insights from the VICTORIA trial
Cited by 16
Semantic Scholar
PROJECTING THE BENEFIT OF VERICIGUAT IN POPULATIONS SIMULATED FROM PARADIGM-HF AND DAPA-HF: INSIGHTS FROM THE VICTORIA TRIAL
Cited by 0
Semantic Scholar
Abstract 12557: Vericiguat Use in a Real-World HFrEF Patient Population: Two Years Post-Launch
Cited by 1
Semantic Scholar
Research Topics
Marine Sponges and Natural Products
(28)
Heart Failure Treatment and Management
(27)
Synthesis and biological activity
(27)
Synthesis and Characterization of Heterocyclic Compounds
(26)
Cardiovascular Function and Risk Factors
(15)
Affiliations
Brigham and Women's Hospital
Merck & Co., Inc., Rahway, NJ, USA (United States)
Partners In Health
Beth Israel Deaconess Medical Center
Harvard University